Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Mol Med Rep. 2021 Jul;24(1). doi: 10.3892/mmr.2021.12169. Epub 2021 May 26.
Cell division cycle‑associated 2 (CDCA2) overexpression has been demonstrated to serve a significant role in tumorigenesis in certain types of cancer. Nevertheless, its role in tumour proliferation and radioresistance in oesophageal squamous cell carcinoma (ESCC) remains to be elucidated. Thus, the present study aimed to elucidate these roles. Data were downloaded from The Cancer Genome Atlas (TCGA) to compare the gene expression profiles. The expression of CDCA2 was higher in ESCC tissues compared with normal tissues. Gene set enrichment analysis was performed based on the ESCC cohorts in TCGA database. This demonstrated that higher expression of CDCA2 was significantly associated with the expression of related components of the cell cycle phase transition and G2/M phase transition pathways. Collectively, the results revealed that CDCA2 could serve as an underlying target to regulate tumour growth and radioresistance among patients with ESCC.
细胞分裂周期相关蛋白 2(CDCA2)的过表达已被证明在某些类型的癌症中在肿瘤发生中起重要作用。然而,其在食管鳞状细胞癌(ESCC)中的肿瘤增殖和放射抵抗作用仍有待阐明。因此,本研究旨在阐明这些作用。从癌症基因组图谱(TCGA)下载数据以比较基因表达谱。结果显示,与正常组织相比,ESCC 组织中 CDCA2 的表达更高。基于 TCGA 数据库中的 ESCC 队列进行基因集富集分析。结果表明,CDCA2 的高表达与细胞周期相转变和 G2/M 相转变途径的相关成分的表达显著相关。综上所述,这些结果表明 CDCA2 可作为调节 ESCC 患者肿瘤生长和放射抵抗的潜在靶标。